USD
$0.00
(0.00%
)At Close (As of Sep 8, 2025)
$158.59M
Market Cap
-
P/E Ratio
-15.54
EPS
$41.30
52 Week High
$3.60
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $40M |
Total Revenue | $57M |
Cost Of Revenue | $17M |
Costof Goods And Services Sold | $17M |
Operating Income | -$83M |
Selling General And Administrative | $119M |
Research And Development | $9.6M |
Operating Expenses | $123M |
Investment Income Net | - |
Net Interest Income | -$2M |
Interest Income | - |
Interest Expense | $2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $4M |
Income Before Tax | -$73M |
Income Tax Expense | -$1K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$73M |
Comprehensive Income Net Of Tax | - |
Ebit | -$71M |
Ebitda | -$67M |
Net Income | -$73M |
Field | Value (USD) |
---|---|
Total Assets | $93M |
Total Current Assets | $42M |
Cash And Cash Equivalents At Carrying Value | $3.3M |
Cash And Short Term Investments | $3.3M |
Inventory | $2.4M |
Current Net Receivables | $26M |
Total Non Current Assets | $51M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $32M |
Intangible Assets Excluding Goodwill | $32M |
Goodwill | $13M |
Investments | - |
Long Term Investments | $2.4M |
Short Term Investments | - |
Other Current Assets | $9.4M |
Other Non Current Assets | - |
Total Liabilities | $286M |
Total Current Liabilities | $260M |
Current Accounts Payable | $53M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $36M |
Total Non Current Liabilities | $26M |
Capital Lease Obligations | $2.2M |
Long Term Debt | $845K |
Current Long Term Debt | $35M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $38M |
Other Current Liabilities | $171M |
Other Non Current Liabilities | $155K |
Total Shareholder Equity | -$193M |
Treasury Stock | - |
Retained Earnings | -$563M |
Common Stock | $24K |
Common Stock Shares Outstanding | $7M |
Field | Value (USD) |
---|---|
Operating Cashflow | $19M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $4M |
Capital Expenditures | $600K |
Change In Receivables | - |
Change In Inventory | $1.5M |
Profit Loss | - |
Cashflow From Investment | -$2.7M |
Cashflow From Financing | -$18M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$73M |
Field | Value (USD) |
---|---|
Gross Profit | $40M |
Total Revenue | $57M |
Cost Of Revenue | $17M |
Costof Goods And Services Sold | $17M |
Operating Income | -$83M |
Selling General And Administrative | $119M |
Research And Development | $9.6M |
Operating Expenses | $123M |
Investment Income Net | - |
Net Interest Income | -$2M |
Interest Income | - |
Interest Expense | $2M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $4M |
Income Before Tax | -$73M |
Income Tax Expense | -$1K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$73M |
Comprehensive Income Net Of Tax | - |
Ebit | -$71M |
Ebitda | -$67M |
Net Income | -$73M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.